Related Experiment Video
Updated: Jul 21, 2026

Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products
Published on: August 22, 2017
Treatment of urinary tract infection with norfloxacin. Analysis of cost
Abstract:
Twenty-five patients with urinary tract infection were treated with norfloxacin, a fluoroquinolone antibacterial with a wide spectrum of activity for an oral agent. Of 22 patients who were evaluable, 20 had complicated urinary tract infection; infection was cured in 19 patients at one week after treatment. Optimal alternative treatments were also selected in norfloxacin's stead, based on each patient's characteristics and the results of susceptibility testing for each isolated pathogen. Direct costs for alternative treatment ranged from $7 to $970. The results indicated that for those patients with suspected or proven urinary tract infection caused by multiresistant bacteria, therapy with norfloxacin may represent a cost-effective choice.
Insights
Norfloxacin effectively treated urinary tract infections in most patients, including those with complicated cases. This fluoroquinolone antibacterial may be a cost-effective option for infections caused by multiresistant bacteria.
Area of Science:
- Infectious Diseases
- Pharmacology
- Urology
Background:
- Urinary tract infections (UTIs) are common, with increasing resistance to antibiotics.
- Complicated UTIs often require broad-spectrum antibacterial agents.
- Norfloxacin is an oral fluoroquinolone with a wide spectrum of activity.
Purpose of the Study:
- To evaluate the efficacy and cost-effectiveness of norfloxacin in treating patients with urinary tract infections.
- To compare norfloxacin treatment with alternative therapies based on susceptibility testing.
Main Methods:
- A study involving 25 patients diagnosed with urinary tract infections.
- Treatment with norfloxacin, an oral fluoroquinolone antibacterial.
- Evaluation of treatment outcomes and direct costs of alternative therapies.
Main Results:
- Of 22 evaluable patients, 20 had complicated UTIs.
- Norfloxacin successfully cured the infection in 19 out of 22 patients one week post-treatment.
- Direct costs for alternative treatments varied significantly, ranging from $7 to $970.
Conclusions:
- Norfloxacin demonstrated high efficacy in treating urinary tract infections, including complicated cases.
- Norfloxacin therapy may be a cost-effective choice for UTIs caused by multiresistant bacteria.
- Individualized alternative treatments were considered alongside norfloxacin therapy.
Related Concept Videos
Urinary Tract Infection I: Introduction
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection IV: Nursing Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Calculi III: Medical Management
Urine Studies II: Urine Culture and Sensitivity Test

